CAPE activates AMPK and Foxo3 signaling to induce growth inhibition and ferroptosis in triple-negative breast cancer
PLOS ONE · 27.12.2024 · 19 (12) · e0315037
DOI: 10.1371/journal.pone.0315037 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 27.12.2024. Verfasst von Qilu Fang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Hangzhou Institute of Medicine (HIM), Zhejiang Cancer Hospital, Zhejiang, Hangzhou, China. Hauptthemen laut MEDLINE: Ferroptosis, Triple Negative Breast Neoplasms, Forkhead Box Protein O3, Cell Proliferation. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Program of Zhejiang Province, Natural Science Foundation of Zhejiang Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Purpose
Approximately 20% of all breast cancer cases are classified as triple-negative breast cancer (TNBC), which represents the most challenging subtype due to its poor prognosis and high metastatic rate. Caffeic acid phenethyl ester (CAPE), the main component extracted from propolis, has been reported to exhibit anticancer activity across various tumor cell types. This study aimed to investigate the effects and mechanisms of CAPE on TNBC.
Methods
MDA-MB-231 and MDA-MB-468 cells were treated with CAPE. CCK8 and colony formation assays were performed to analyze cell proliferation. Western blot, TUNEL and Annexin V-FITC/PI staining methods were employed to assess cell apoptosis. ROS, MDA, SOD, GSH, C11-bodipy staining, along with measurements of GPX4 and Ferritin levels, were utilized for ferroptosis detection. Western blot and immunofluorescence analysis were used to assess key regulatory molecules. The cells were subjected to treatments involving ferroptosis inhibition, AMPK inhibition, or Foxo3 inhibition, followed by CAPE administration to assess cell proliferation, apoptosis, and ferroptosis. Tumor xenografts were used to evaluate the antitumor efficacy of CAPE.
Results
CAPE not only suppressed cell proliferation but also promoted apoptosis followed by ferroptosis. Co-incubation with Fer-1 (a ferroptosis inhibitor) diminished CAPE’s suppressive effects on proliferation and apoptosis induction. CAPE treatment enhanced the phosphorylation of AMPK and promoted the nuclear translocation of Foxo3. Inhibition of both AMPK and Foxo3 by siRNAs or inhibitors (Compc, TIC10) reversed the growth retardation induced by CAPE as well as its pro-apoptotic effects leading to ferroptosis. Specifically, AMPK inhibition abrogated the CAPE-induced nuclear translocation of Foxo3. CAPE significantly inhibited tumor growth in nude mice bearing TNBC xenografts.
Conclusion
CAPE possesses a resistance effect on TNBC via activation of AMPK and Foxo3 signaling pathways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Hangzhou Institute of Medicine (HIM), Zhejiang Cancer Hospital, Zhejiang, Hangzhou, China.
- School of Medical Technology and Information Engineering, Zhejiang Chinese Medical University, Zhejiang, Hangzhou, China.
- School of Pharmacy, Nanchang University, Jiangxi, Nanchang, China.
ORCID-Profile: Qilu Fang, Wenxiu Xin
Förderung
- Science and Technology Program of Zhejiang Province
- Natural Science Foundation of Zhejiang Province
- National Natural Science Foundation of China
Zitieren
APA
Fang, Q., Fang, Q., Cheng, R., Feng, T., & Xin, W. (2024). CAPE activates AMPK and Foxo3 signaling to induce growth inhibition and ferroptosis in triple-negative breast cancer. PLOS ONE, 19(12), e0315037. https://doi.org/10.1371/journal.pone.0315037
Vancouver
Fang Q, Fang Q, Cheng R, Feng T, Xin W. CAPE activates AMPK and Foxo3 signaling to induce growth inhibition and ferroptosis in triple-negative breast cancer. PLOS ONE. 2024;19(12):e0315037. doi:10.1371/journal.pone.0315037
BibTeX
@article{Fang2024,
author = {Fang, Qilu and Fang, Qichuan and Cheng, Rui and Feng, Tingting and Xin, Wenxiu},
title = {CAPE activates AMPK and Foxo3 signaling to induce growth inhibition and ferroptosis in triple-negative breast cancer},
journal = {PLOS ONE},
year = {2024},
volume = {19},
number = {12},
pages = {e0315037},
doi = {10.1371/journal.pone.0315037}
}
EUVIMED